Achondrogenesis, type II (ACG2; MIM 200610) and Hypochondrogenesis (MIM 200610) are lethal conditions caused by defects in COL2A1. Although they share phenotypic characteristics, ACG2 is considered more severe. Affected fetuses and infants have a large head, soft cranium, flat face, barrel shaped trunk, and short long bones. In ACG2 the entire spine and sacrum may not be more

Tests Available

By gene: COL2A1
Next Generation Sequencing
Test Code: 1005
Deletion / Duplication
Test Code: 1006
NGS/Del Dup Comprehensive
Test Code: 1446

Test Details

Technical Information
Disease Groups: 
Skeletal Dysplasias
CPT Codes: 
81479 x 1
Turnaround Time: 
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Non-Prenatal Specimens: 
  1. Whole blood: purple-top (EDTA) tube, minimum of 3 ml
  2. Genomic DNA: a minimum of 3 µg (at a concentration of at least 30 ng/µl)
  3. Fibroblasts: 2 confluent T-25 flasks
  4. Saliva: only samples collected in Oragene DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children are accepted
Prenatal Specimens: 
  1. Cultured cells: 2 confluent T-25 flasks derived from amnio or CVS samples
  2. Genomic DNA: a minimum of 3 µg (at a concentration of at least 30 ng/µl)
Ship all specimen types at room temperature by overnight courier. Do not freeze.

Search Tests

TIP: enter a partial disorder name or gene to widen your search